# Botanical Drug Development: Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/botanical-drug-development-guidance-for-industry/bec78068-96c3-424e-b070-7b4ecfcfc8bf

> FDA guidance document: Botanical Drug Development: Guidance for Industry. Issue date: December 29, 2016. Get complete insights and analysis.

---

## Details

- Title: Botanical Drug Development: Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-12-29
- Last Changed: 2020-05-07
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2000-D-0103">FDA-2000-D-0103</a>

## Related Documents

- [ANDA Submissions -- Refuse-to-Receive Standards Rev2](https://www.globalkeysolutions.net/guidances/guidance-document/anda-submissions-refuse-to-receive-standards-rev2/78b570c1-44d2-45b3-b780-47480621496b)
- [Regulatory Classification of Pharmaceutical Co-Crystals](https://www.globalkeysolutions.net/guidances/guidance-document/regulatory-classification-of-pharmaceutical-co-crystals/b288c932-6da7-45b6-b036-5876350c1f0f)
- [SUPAC: Manufacturing Equipment Addendum](https://www.globalkeysolutions.net/guidances/guidance-document/supac-manufacturing-equipment-addendum/a362d5e9-2422-4c5a-bb5b-e13556f3eaa2)